Federated Hermes, Inc. Catalyst Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 54,141 shares of CPRX stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,141

Previous 53,978 0.3%

Holding current value

$1.12 Million

Previous $836,000 28.71%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.19 - $21.35 $2,475 - $3,480	163 Added 0.3%	54,141 $1.08 Million
Q2 2024 Aug 08, 2024	SELL	$14.68 - $16.92 $44 - $50	-3 Reduced 0.01%	53,978 $836,000
Q1 2024 May 14, 2024	SELL	$13.18 - $17.11 $990,911 - $1.29 Million	-75,183 Reduced 58.21%	53,981 $860,000
Q4 2023 Jan 31, 2024	SELL	$11.78 - $17.29 $492,922 - $723,482	-41,844 Reduced 24.47%	129,164 $2.17 Million
Q3 2023 Nov 13, 2023	BUY	$11.69 - $15.02 $891,526 - $1.15 Million	76,264 Added 80.49%	171,008 $2 Million
Q2 2023 Aug 14, 2023	BUY	$11.5 - $18.08 $614,997 - $966,882	53,478 Added 129.59%	94,744 $1.27 Million
Q1 2023 May 08, 2023	SELL	$14.34 - $21.05 $344 - $505	-24 Reduced 0.06%	41,266 $684,000
Q4 2022 Feb 13, 2023	BUY	$12.25 - $19.5 $503,230 - $801,060	41,080 Added 19561.9%	41,290 $767,000
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $5,951 - $13,083	-843 Reduced 80.06%	210 $4,000
Q2 2022 Aug 15, 2022	SELL	$6.23 - $8.57 $4.08 Million - $5.62 Million	-655,319 Reduced 99.84%	1,053 $8,000
Q1 2022 May 13, 2022	SELL	$5.31 - $8.31 $5,745 - $8,991	-1,082 Reduced 0.16%	656,372 $5.44 Million
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $1,120 - $1,601	215 Added 0.03%	657,454 $4.45 Million
Q3 2021 Nov 15, 2021	BUY	$4.85 - $6.04 $146,673 - $182,661	30,242 Added 4.82%	657,239 $3.48 Million
Q2 2021 Aug 16, 2021	BUY	$4.29 - $6.05 $510 - $719	119 Added 0.02%	626,997 $3.61 Million
Q1 2021 May 13, 2021	SELL	$3.45 - $4.69 $17,156 - $23,323	-4,973 Reduced 0.79%	626,878 $2.89 Million
Q4 2020 Feb 12, 2021	SELL	$2.97 - $3.83 $2,913 - $3,757	-981 Reduced 0.16%	631,851 $2.11 Million
Q3 2020 Nov 12, 2020	BUY	$2.97 - $5.08 $217,953 - $372,795	73,385 Added 13.12%	632,832 $1.88 Million
Q2 2020 Aug 13, 2020	BUY	$3.48 - $5.05 $1.04 Million - $1.51 Million	298,251 Added 114.19%	559,447 $2.59 Million
Q1 2020 May 13, 2020	BUY	$2.61 - $5.21 $657,338 - $1.31 Million	251,854 Added 2695.93%	261,196 $1.01 Million
Q4 2019 Feb 14, 2020	SELL	$3.67 - $5.7 $416,086 - $646,237	-113,375 Reduced 92.39%	9,342 $35,000
Q3 2019 Nov 14, 2019	BUY	$3.89 - $7.43 $469,814 - $897,358	120,775 Added 6219.1%	122,717 $652,000
Q2 2019 Aug 14, 2019	BUY	$2.7 - $6.11 $5,243 - $11,865	1,942 New	1,942 $7,000
Q1 2018 May 09, 2018	SELL	$2.39 - $4.01 $1,426 - $2,393	-597 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.51 - $4.4 $1,498 - $2,626	597	597 $0

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Catalyst Pharmaceuticals, Inc. Transaction History